Sarepta Therapeutics Stock Price (NASDAQ:SRPT)

Add to My Stocks
$151.95 $1.63 (1.06%) SRPT stock closing price Sep 19, 2018 (Closing)
Prev Close* : $153.58
Market Cap:
Day Low: $150.5
52 Week Low: $42.97
Open: $153.86
Volume: -
Day High: $154.97
52 Week High: $176.50

Latest Stock Market News

Latest Articles

Sarepta Therapeutics News - From Partners

SRPT Stockcharts

View SRPT PE ratio, PS ratio stocks charts and compare with peers.
SRPT Chart
Note: Compare Sarepta Therapeutics stock price history with the index and industry peers.

Sarepta Therapeutics Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Sarepta Therapeutics Returns

(return on equity)

Sarepta Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

SRPT Industry Peers

Company Price Change (%)
Genmab (GNMSF)15812.25 (7.2%)
Juno Therapeutics (JUNO)86.960 (0%)
Ptc Therapeutics (PTCT)45.371.82 (3.86%)
Vertex Pharma (VRTX)176.60.52 (0.29%)
Summit Therapeutics (SMMT)2.340.02 (0.86%)
Alnylam Pharma (ALNY)94.821.07 (1.14%)
Hemispherx Biopharma (HEB)0.230 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ELOXX PHARMACT (ELOX)14.791.44 (10.79%)
Fate Therapeutics (FATE)13.361.16 (9.51%)
Nymox Pharmaceutical (NYMX)2.680.15 (5.93%)
Acadia Pharma (ACAD)15.10.82 (5.74%)
Mirati Therapeutics (MRTX)57.32.8 (5.14%)
Vericel Corp (VCEL)14.050.65 (4.85%)
Agenus (AGEN)20.09 (4.71%)
Top gainers from Medical-Biomed-Genetics industry
* As of Sep 19, 2018
CompanyPriceChange (%)
OncoMed Pharma (OMED)2.80.11 (3.78%)
Kindred Biosciences (KIN)12.950.5 (3.72%)
Dicerna Pharma (DRNA)16.320.61 (3.6%)
Uniquire (QURE)38.561.34 (3.36%)
Organovo (ONVO)1.160.04 (3.33%)
Enzo Biochem (ENZ)4.390.15 (3.3%)
Keryx Biopharma (KERX)2.960.1 (3.27%)
Top losers from Medical-Biomed-Genetics industry
* As of Sep 19, 2018

Sarepta Therapeutics Inc Stock News - Partner Headlines

Weekly CEO Buys Highlight   on Aug 20, 2018

Sarepta Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues154.58M5.42M1.25M9.75M14.21M
Net Income-50.68M-267.26M-220.03M-135.78M-111.98M
Total Operating Expense318.85M272.01M221.43M143.54M104.49M
View Sarepta Therapeutics income statement
balance sheet20172016201520142013
Total Assets1.31B424.1M273.78M295.03M291.56M
Total Liabilities518.74M87.41M83.43M47.38M44.37M
Shareholders Equity789.21M336.69M190.34M247.65M247.19M
View Sarepta Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-97.46M-15.76M31.98M-22.13M12.26M
Net Cash from (used by) Operating Activities-231.99M-245.82M-149.46M-128.53M-64.69M
Increase (Decrease) in Prop Plant And Equipment-12M-5.34M-3.4M-25.44M-2.37M
View Sarepta Therapeutics cash flow statement

Sarepta Therapeutics Stock Message Board

Sarepta Therapeutics stock lost 1.06%, and the last close price as of Sep 19, 2018 is $151.95 for SRPT stock. Looking at Sarepta Therapeutics market capitalization, which currently stands at $10.2B, we can say that SRPT stock is a Large Cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Sarepta Therapeutics stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy SRPT stock than sell it, then Sarepta Therapeutics stock price goes up. Conversely, if more investors wanted to sell SRPT stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 588,454 on the last trading day, as is evident from Sarepta Therapeutics stock chart, and SRPT stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Sarepta Therapeutics dividend per share was 0.00 during the last quarter. Sarepta Therapeutics stock price history, gives the entire historical data for SRPT stock.